Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Dierks C, Seufert J, Aumann K, Ruf J, Klein C, Kiefer S, Rassner M, Boerries M, Zielke A, la Rosee P, Meyer PT, Kroiss M, Weißenberger C, Schumacher T, Metzger P, Weiss H, Smaxwil C, Laubner K, Duyster J, von Bubnoff N, Miething C, Thomusch O. Dierks C, et al. Among authors: rassner m. Thyroid. 2021 Jul;31(7):1076-1085. doi: 10.1089/thy.2020.0322. Epub 2021 Apr 15. Thyroid. 2021. PMID: 33509020 Free PMC article.
Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST).
Jilg S, Rassner M, Maier J, Waldeck S, Kehl V, Follo M, Philipp U, Sauter A, Specht K, Mitschke J, Lange T, Bauer S, Jost PJ, Peschel C, Duyster J, Gaiser T, Hohenberger P, von Bubnoff N. Jilg S, et al. Among authors: rassner m. Int J Cancer. 2019 Oct 15;145(8):2292-2303. doi: 10.1002/ijc.32282. Epub 2019 Apr 29. Int J Cancer. 2019. PMID: 30882891 Free article. Clinical Trial.
Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management.
Wehrle J, Philipp U, Jolic M, Follo M, Hussung S, Waldeck S, Deuter M, Rassner M, Braune J, Rawluk J, Greil C, Waller CF, Becker H, Duque-Afonso J, Illert AL, Fritsch RM, Meiss F, Duyster J, von Bubnoff N, Scherer F. Wehrle J, et al. Among authors: rassner m. Diagnostics (Basel). 2020 Aug 2;10(8):550. doi: 10.3390/diagnostics10080550. Diagnostics (Basel). 2020. PMID: 32748806 Free PMC article.
Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer.
Waldeck S, Mitschke J, Wiesemann S, Rassner M, Andrieux G, Deuter M, Mutter J, Lüchtenborg AM, Kottmann D, Titze L, Zeisel C, Jolic M, Philipp U, Lassmann S, Bronsert P, Greil C, Rawluk J, Becker H, Isbell L, Müller A, Doostkam S, Passlick B, Börries M, Duyster J, Wehrle J, Scherer F, von Bubnoff N. Waldeck S, et al. Among authors: rassner m. Mol Oncol. 2022 Jan;16(2):527-537. doi: 10.1002/1878-0261.13116. Epub 2021 Oct 31. Mol Oncol. 2022. PMID: 34653314 Free PMC article.
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers.
Frank B, Ihorst G, Herget G, Schäfer H, Neubauer J, Calba MA, Textor D, Möller MD, Wenger S, Jung J, Waldschmidt J, Miething C, Rassner M, Greil C, Wäsch R, Engelhardt M. Frank B, et al. Among authors: rassner m. Ann Hematol. 2023 Mar;102(3):603-611. doi: 10.1007/s00277-022-05051-y. Epub 2022 Dec 5. Ann Hematol. 2023. PMID: 36464695 Free PMC article.
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab.
Shoumariyeh K, Jung J, Rassner M, Dold SM, Riebl V, Pantic M, Herget G, Marks R, Lübbert M, Wäsch R, Engelhardt M. Shoumariyeh K, et al. Among authors: rassner m. Ann Hematol. 2021 Jun;100(6):1637-1640. doi: 10.1007/s00277-021-04490-3. Epub 2021 Mar 13. Ann Hematol. 2021. PMID: 33712868 Free PMC article. No abstract available.
28 results